The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tyra Biosciences Inc shares valued at $250,000 were sold by MORE ROBERT J on Dec 19 ’25. At $25.00 per share, MORE ROBERT J sold 10,000 shares. The insider’s holdings dropped to 3,823,425 shares worth approximately $100.52 million following the completion of this transaction.
Also, Bensen Daniel sold 8,000 shares, netting a total of over 181,159 in proceeds. Following the sale of shares at $22.64 each, the insider now holds 162,981 shares.
Before that, Daniel Bensen had added 8,000 shares to its account. In a trade valued at $180,000, the Officer bought Tyra Biosciences Inc shares for $22.50 each.
As published in their initiating research note from Raymond James on September 03, 2025, Tyra Biosciences Inc [TYRA] has been a Strong buy and the price target has been revised to $35. As of January 07, 2025, UBS has initiated its “Buy” rating for TYRA. Earlier on October 18, 2024, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for TYRA stock which previously was a “a Neutral”.
Analyzing TYRA Stock Performance
On last trading session, Tyra Biosciences Inc [NASDAQ: TYRA] rose 3.34% to $26.29. The stock’s lowest price that day was $25.42, but it reached a high of $26.41 in the same session. During the last five days, there has been a surge of approximately 1.78%. Over the course of the year, Tyra Biosciences Inc shares have jumped approximately 86.85%. Shares of the company reached a 52-week high of $26.41 on 12/31/25 and a 52-week low of $6.42 on 04/09/25.
Support And Resistance Levels for Tyra Biosciences Inc (TYRA)
According to the 24-hour chart, there is a support level at 25.63, which, if violated, would cause prices to drop to 24.97. In the upper region, resistance lies at 26.68. The next price resistance is at 27.07. RSI (Relative Strength Index) is 73.24 on the 14-day chart, showing overbought technical sentiment.
Is Tyra Biosciences Inc subject to short interest?
Stocks of Tyra Biosciences Inc saw a sharp steep in short interest on 2025-12-15 dropping by -0.14 million shares to 4.24 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 4.38 million shares. A decline of -3.22% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.2 of the overall float, the days-to-cover ratio (short ratio) decline to 7.2.
Which companies own the most shares of Tyra Biosciences Inc (TYRA)?
In terms of Tyra Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 36.5 in the next 12 months, up nearly 43.47% from the previous closing price of $25.44. Analysts anticipate Tyra Biosciences Inc stock to reach 37 by 2026, with the lowest price target being 36. In spite of this, 2 analysts ranked Tyra Biosciences Inc stock as Buy at the end of 2026. On August 15, 2024, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $33.
